Venous Thromboembolism and Associated Factors in Hospitalized Patients with COVID-19 at Addis Ababa COVID-19 Field Hospital, Ethiopia

References

• Alwafi H, Naser AY, Qanash S. Predictors of Length of Hospital Stay, Mortality, and Outcomes among Hospitalised COVID-19 Patients in Saudi Arabia:No Title. J Multidiscip Healthc. 2021;14:839–852. doi:10.2147/JMDH.S304788
   PubMed Web of Science ®Google Scholar
• Kaminetzky M, Moore W, Fansiwala K, et al. Pulmonary Embolism at CT Pulmonary Angiography in Patients with COVID-19. Radiol Cardiothorac Imaging. 2020;2(4):e200308. doi:10.1148/ryct.2020200308
   PubMedGoogle Scholar
• Gautam S. The Influence of COVID-19 on Air Quality in India: a Boon or Inutile. Bull Environ Contam Toxicol. 2020;104(6):724–726. doi:10.1007/s00128-020-02877-y
   PubMed Web of Science ®Google Scholar
• Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18(March):1–4. doi:10.18332/tid/119324
   Web of Science ®Google Scholar
• Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):71–77. doi:10.1513/pats.200407-038MS
   PubMedGoogle Scholar
• Chi G, Lee JJ, Jamil A, et al. Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: a Systematic Review and Meta-Analysis. J Clin Med. 2020;9(8):2489. doi:10.3390/jcm9082489
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. doi:10.1111/jth.14817
   PubMed Web of Science ®Google Scholar
• Temgoua MN, Kuaté LM, Ngatchou W, et al. Thromboembolic risks in patients with COVID-19: major concern to consider in our management. Pan Afr Med J. 2020;35(Supp 2):80. doi:10.11604/pamj.supp.2020.35.2.22945
   Google Scholar
• Moll M, Zon RL, Sylvester KW, et al. VTE in ICU Patients With COVID-19. Chest. 2020;158(5):2130–2135. doi:10.1016/j.chest.2020.07.031
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi:10.1016/j.jacc.2020.04.031
   PubMed Web of Science ®Google Scholar
• Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT. 30-Year mortality after venous thromboembolism a population-based cohort study. Circulation. 2014;130(10):829–836. doi:10.1161/CIRCULATIONAHA.114.009107
   PubMed Web of Science ®Google Scholar
• Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424. doi:10.1111/jth.14830
   PubMed Web of Science ®Google Scholar
• Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1995–2002. doi:10.1111/jth.14888
   PubMed Web of Science ®Google Scholar
• Giannis D, Barish MA, Goldin M, et al. Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. J Thromb Thrombolysis. 2021;51(4):897–901. doi:10.1007/s11239-021-02413-7
   PubMed Web of Science ®Google Scholar
• Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72–81. doi:10.1007/s11239-020-02138-z
   PubMed Web of Science ®Google Scholar
• Ministry of Health-Ethiopia. National Comprehensive COVID 19 Clinical Management Handbook for Ethiopia; 2020 September:1–167.
   Google Scholar
• Zhang L, Feng X, Zhang D, et al. Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: prevalence, Risk Factors, and Outcome. Circulation. 2020;142(2):114–128. doi:10.1161/CIRCULATIONAHA.120.046702
   PubMed Web of Science ®Google Scholar
• Wu C, Liu Y, Cai X, Zhang W, Li Y, Fu C. Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: a Meta-Analysis. Front Med. 2021;8:603558.
   Web of Science ®Google Scholar
• Vardavas CI, Nikitara K, Tang N, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. J Thromb Haemost. 2020;18(1):2489. doi:10.1016/j.jvsv.2021.01.012
   Google Scholar
• Monfardini L, Morassi M, Botti P, et al. Pulmonary thromboembolism in hospitalised COVID-19 patients at moderate to high risk by Wells score: a report from Lombardy, Italy. Br J Radiol. 2020;93(1113):1–6. doi:10.1259/bjr.20200407
   Google Scholar
• Bobadilla-Rosado LO, Mier Y, Teran-Ellis S, Lopez-Pena G, Anaya-Ayala JE, Hinojosa CA. Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19. Clin Appl Thromb. 2021;27:0–3. doi:10.1177/10760296211008988
   Web of Science ®Google Scholar
• Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–1746. doi:10.1111/jth.14869
   PubMed Web of Science ®Google Scholar
• Malato A, Dentali F, Siragusa S, et al. The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes. Blood Transfus. 2015;13(4):559–568. doi:10.2450/2015.0277-14
   PubMed Web of Science ®Google Scholar
• Buckner TW, Key NS. Venous thrombosis in blacks. Circulation. 2012;125(6):837–839. doi:10.1161/CIRCULATIONAHA.111.073098
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang D, Zheng T, Yu Y, Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51(1):33–39. doi:10.1007/s11239-020-02181-w
   PubMed Web of Science ®Google Scholar
• Sakr Y, Giovini M, Leone M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care. 2020;10(1). doi:10.1186/s13613-020-00741-0
   PubMed Web of Science ®Google Scholar
• Kyriakoulis KG, Kokkinidis DG, Kyprianou IA, et al. Venous thromboembolism in the era of COVID-19. Phlebology. 2021;36(2):91–99. doi:10.1177/0268355520955083
   PubMed Web of Science ®Google Scholar
• Ozsu S, Gunay E, Konstantinides SV. A review of venous thromboembolism in COVID-19: a clinical perspective. Clin Respir J. 2021;15(5):506–512. doi:10.1111/crj.13330
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x
   PubMed Web of Science ®Google Scholar
• Morrone D, Morone V. Acute pulmonary embolism: focus on the clinical picture. Korean Circ J. 2018;48(5):365–381. doi:10.4070/kcj.2017.0314
   PubMed Web of Science ®Google Scholar